Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 9A, Urine - Screen with Reflex to Confirmation/Quantitation (0092187) is recommended.
Qualitative Enzyme Multiplied Immunoassay Technique/Alcohol Dehydrogenase
Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)
Specimens exposed to repeated freeze/thaw cycles.
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years
Effective August 17, 2015
|Drugs Covered and Cutoff Concentrations
|THC (Cannabinoids)||20 ng/mL|
|MDMA (Ecstasy)||500 ng/mL|
This is a screening test only. False positive and false negative results can occur. Positive results are not automatically reflexed to a confirmatory test Confirmation by GC/MS and/or LC-MS/MS must be requested separately. Confirmatory testing for drugs and/or drug classes detected by this screening test is recommended.
The absence of expected drug(s) and/or drug metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
The following opioids are not detected in this test, but can be ordered separately: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to aruplab.com for test information.
For medical purposes only; not valid for forensic use.
No compliance statements are in use for this test.
To order testing for individual opioids, refer to Fentanyl and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 0092570), Buprenorphine and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2010092), Meperidine and Metabolite Quantitative, Urine (ARUP test code 3000248), Tramadol and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).
|Component Test Code*||Component Chart Name||LOINC|
|0090381||Amphetamines, Urn, Screen||3349-8|
|0090382||Barbiturates, Urn, Screen||3377-9|
|0090383||Benzodiazepines, Urn, Screen||3390-2|
|0090387||Propoxyphene, Urn, Screen||19141-1|
|0090388||Cocaine, Urn, Screen||3397-7|
|0090389||Methadone, Urn, Screen||3773-9|
|0090396||Opiates, Urn, Screen||3879-4|
|0090397||Phencyclidine, Urn, Screen||19659-2|
|0090398||THC, Urn, Screen||18282-4|
|0090419||Drug Panel 9A, Screen Only - Comments|
|0090488||Alcohol, Urn, Screen||5644-0|
|2004776||Oxycodone, Urn, Screen||19644-4|
|2004778||MDMA, Urn, Screen||19571-9|
- Pain Management